🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of the study are: * To evaluate the long-term safet...
Status
Completed
Location
Clinical Trial Site
Start Date
2018-03-13
Trial ID
NCT03409744
Treatments Being Tested
This study is researching experimental drugs called ALN-ANG3 and evinacumab...
Status
Recruiting
Location
Apogee Clinical Research, LLC
Start Date
2026-01-09
Trial ID
NCT07271186
Treatments Being Tested
The primary objective for Part A of the study is to assess the pharmacokine...
Status
Completed
Location
Regeneron Research Site
Start Date
2020-06-29
Trial ID
NCT04233918
Treatments Being Tested
The primary objective of the study is to determine the proportion of patien...
Status
Terminated
Location
Radin Cardivascular Medical Group, Inc
Start Date
2021-07-12
Trial ID
NCT04863014
Treatments Being Tested
Provide compassionate use of evinacumab...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06500598
Treatments Being Tested
This is an open-label, single-arm study to assess the reduction of low-dens...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-04
Trial ID
NCT02265952
Treatments Being Tested
Phase 1, first-in-human, randomized, ascending single-dose, placebo-control...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01749878
The primary objective of the study is to compare the safety and tolerabilit...
Status
Completed
Location
WCCT Global, Inc.
Start Date
2017-05-16
Trial ID
NCT03146416
Treatments Being Tested
The primary objective of the study is to evaluate the reduction of LDL-C by...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2017-11-10
Trial ID
NCT03175367
Treatments Being Tested
This is an open-label study designed to evaluate the long-term safety and e...
Status
Completed
Location
Ecogene-21
Start Date
2023-02-21
Trial ID
NCT05611528
Treatments Being Tested